Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
The current Moderna(MRNA) stock price is $30.30, with a market capitalization of 11.93B. The stock trades at a price-to-earnings (P/E) ratio of -3.71.
During the trading session on 2025-12-17, Moderna(MRNA) shares reached a daily high of $31.70 and a low of $29.71. At a current price of $30.30, the stock is +2.0% higher than the low and still -4.4% under the high.
Trading activity shows a volume of 11.56M, compared to an average daily volume of 10.03M.
The stock's 52-week range extends from a low of $22.28 to a high of $48.92.
The stock's 52-week range extends from a low of $22.28 to a high of $48.92.
MRNA News
Earlier this week, Moderna received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use recommending EU marke...
Moderna (MRNA) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketi...
Moderna (MRNA) has been drifting lower this year, even as its pipeline and revenue trends show some signs of stabilization. That disconnect is what has put the...
Analyst ratings
62%
of 26 ratingsMore MRNA News
Moderna (MRNA) has received a new Hold rating, initiated by Jefferies analyst, Andrew Tsai. TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-b...
Moderna (NASDAQ:MRNA) extended gains for the seventh consecutive trading session, with the stock closing 2.14% higher at $29.65 on Thursday. MRNA has added 20....
The US risks falling behind in biotechnology as the government cuts funding and skepticism over vaccines grows, according to Moderna Inc.’s co-founder and Chair...
